Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression (Q39085695)

8 September 2017

title

Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression (English)

1 reference

8 September 2017

1 reference

Nir Kleinmann

1

1 reference

8 September 2017

Wilhelmina C M Duivenvoorden

2

1 reference

8 September 2017

Sarah N Hopmans

3

1 reference

8 September 2017

Laura K Beatty

4

1 reference

8 September 2017

Shengjun Qiao

5

1 reference

8 September 2017

Daniel Gallino

6

1 reference

8 September 2017

Sarka Lhotak

7

1 reference

8 September 2017

Dean Daya

8

1 reference

8 September 2017

Athanasios Paschos

9

1 reference

8 September 2017

Richard C Austin

10

1 reference

8 September 2017

Jehonathan H Pinthus

11

1 reference

8 September 2017

publication date

5 October 2013

1 reference

Clinical & Experimental Metastasis

8 September 2017

published in

1 reference

8 September 2017

volume

31

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

169-183

1 reference

The role of the novel adipocyte-derived hormone adiponectin in human disease

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin: A novel adipokine linking adipocytes and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Circulating adiponectin and endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Prostate cancer and adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Low adiponectin levels are associated with renal cell carcinoma: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Changing views of the role of matrix metalloproteinases in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

AMPK: a key regulator of energy balance in the single cell and the whole organism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Understanding the importance of smart drugs in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Systemic therapy for metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Combination systemic therapy for advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Targeted therapies in metastatic renal cancer in 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin receptor expression in human malignant tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Impact of AdipoR1 expression on breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin as a growth inhibitor in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

TSC2 regulates VEGF through mTOR-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Characterization of phosphatidylinositol 3-kinase-dependent phosphorylation of the hydrophobic motif site Thr(389) in p70 S6 kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

The genetic basis of kidney cancer: a metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-013-9618-1

Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study

21 January 2018

1 reference

12 December 2020

Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway

1 reference

12 December 2020

Adiponectin and adiponectin receptor in relation to colorectal cancer progression

1 reference

12 December 2020

Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma

1 reference

12 December 2020

Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3

1 reference

12 December 2020

Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice

1 reference

12 December 2020

Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma

1 reference

12 December 2020

Expression of matrix metalloproteinase-2 in renal cell carcinoma

1 reference

12 December 2020

Association of serum adiponectin levels with breast cancer risk

1 reference

12 December 2020

Presence and enzymatic activity of prostate-specific antigen in archival prostate cancer samples

1 reference

12 December 2020

Obesity, hypertension, and the risk of kidney cancer in men

1 reference

12 December 2020

Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells

1 reference

12 December 2020

Activation of the mTOR signaling pathway in renal clear cell carcinoma

1 reference

12 December 2020

Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma

1 reference

12 December 2020

Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study

1 reference

12 December 2020

10.1007/S10585-013-9618-1

Identifiers

DOI

1 reference

8 September 2017

1 reference